{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:54:47Z","timestamp":1781830487235,"version":"3.54.5"},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ymthe.2026.04.007","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:25:39Z","timestamp":1776425139000},"page":"2534-2535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effector CD8 T cells show additional weaponry during T cell-mediated allograft rejection"],"prefix":"10.1016","volume":"34","author":[{"given":"Robert L.","family":"Fairchild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.04.007_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/ajt.14565","article-title":"T cell-mediated rejection is a major determinant of inflamamtion in scarred areas in kidney allografts","volume":"18","author":"Lefaucheur","year":"2018","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ymthe.2026.04.007_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/TP.0b013e318259407f","article-title":"The implications of acute rejection for allograft survival in contemparary U.S. kidney transplantation","volume":"94","author":"Lentine","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2026.04.007_bib3","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00007890-199304000-00013","article-title":"Risk factor for chronic rejection in renal allograft recipients","volume":"55","author":"Almond","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2026.04.007_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170191","article-title":"Single cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality","volume":"133","author":"Shi","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.04.007_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: Natural Killer cell activation and regulation","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.007_bib6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","article-title":"Natural killer cells and other innate lymphoid cells in cancer","volume":"18","author":"Chiossone","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.007_bib7","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","article-title":"NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection","volume":"10","author":"Hidalgo","year":"2010","journal-title":"Am. J. Transpl."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:32:21Z","timestamp":1781829141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626002686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1525001626002686"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.007","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effector CD8 T cells show additional weaponry during T cell-mediated allograft rejection","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.024","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}